790 In RL95–2 and KLE model cell lines of moderately and poorly differentiated endometrial carcinoma, estrogens can be formed via the sulfatase pathway

R Pavlič; K Marton; M Gjorgoska; M Sinreih; E Hafner; S Poschner; W Jäger; TL Rižner

doi:10.1136/ijgc-2021-ESGO.196

Article info

Endometrial cancer

790 In RL95–2 and KLE model cell lines of moderately and poorly differentiated endometrial carcinoma, estrogens can be formed via the sulfatase pathway

Free

Authors

R Pavlič University of Ljubljana, Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Ljubljana, Slovenia PubMed articles Google scholar articles
K Marton University of Ljubljana, Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Ljubljana, Slovenia PubMed articles Google scholar articles
M Gjorgoska University of Ljubljana, Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Ljubljana, Slovenia PubMed articles Google scholar articles
M Sinreih University of Ljubljana, Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Ljubljana, Slovenia PubMed articles Google scholar articles
E Hafner University of Ljubljana, Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Ljubljana, Slovenia PubMed articles Google scholar articles
S Poschner University of Vienna, Department of Pharmaceutical Chemistry, Vienna, Austria PubMed articles Google scholar articles
W Jäger University of Vienna, Department of Pharmaceutical Chemistry, Vienna, Austria PubMed articles Google scholar articles
TL Rižner University of Ljubljana, Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Ljubljana, Slovenia PubMed articles Google scholar articles

Citation

Pavlič R, Marton K, Gjorgoska M, et al

790 In RL95–2 and KLE model cell lines of moderately and poorly differentiated endometrial carcinoma, estrogens can be formed via the sulfatase pathway

International Journal of Gynecologic Cancer 2021;31:A123.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password